Peddock Capital Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $326K | Buy |
3,154
+4
| +0.1% | +$357 | 0.07% | 129 |
|
|
2026
Q1 | $226K | Sell |
3,150
-4
| -0.1% | -$308 | 0.05% | 150 |
|
|
2025
Q4 | $250K | Buy |
3,154
+13
| +0.4% | +$1.02K | 0.05% | 144 |
|
|
2025
Q3 | $237K | Sell |
3,141
-1,113
| -26% | -$76.3K | 0.05% | 152 |
|
|
2025
Q2 | $293K | Sell |
4,254
-617
| -13% | -$40.5K | 0.07% | 134 |
|
|
2025
Q1 | $330K | Sell |
4,871
-1,214
| -20% | -$72.6K | 0.08% | 126 |
|
|
2024
Q4 | $273K | Sell |
6,085
-11,222
| -65% | -$630K | 0.07% | 138 |
|
|
2024
Q3 | $1.09M | Sell |
17,307
-2,121
| -11% | -$124K | 0.26% | 77 |
|
|
2024
Q2 | $1.15M | Sell |
19,428
-4,972
| -20% | -$311K | 0.3% | 75 |
|
|
2024
Q1 | $1.95M | Buy |
24,400
+1,894
| +8% | +$145K | 0.51% | 52 |
|
|
2023
Q4 | $1.78M | Buy |
22,506
+735
| +3% | +$52.3K | 0.54% | 47 |
|
|
2023
Q3 | $1.52M | Buy |
21,771
+397
| +2% | +$28.1K | 0.51% | 49 |
|
|
2023
Q2 | $1.48M | Buy |
21,374
+538
| +3% | +$38.3K | 0.49% | 53 |
|
|
2023
Q1 | $1.55M | Buy |
20,836
+772
| +4% | +$64.7K | 0.54% | 50 |
|
|
2022
Q4 | $1.87M | Sell |
20,064
-1,405
| -7% | -$136K | 0.72% | 39 |
|
|
2022
Q3 | $2.05M | Sell |
21,469
-140
| -0.6% | -$13.9K | 0.84% | 29 |
|
|
2022
Q2 | $2M | Buy |
21,609
+686
| +3% | +$67K | 0.78% | 31 |
|
|
2022
Q1 | $2.12M | Buy |
20,923
+6,377
| +44% | +$670K | 0.69% | 39 |
|
|
2021
Q4 | $1.5M | Buy |
14,546
+378
| +3% | +$34.9K | 0.5% | 54 |
|
|
2021
Q3 | $1.2M | Buy |
14,168
+28
| +0.2% | +$2.35K | 0.43% | 64 |
|
|
2021
Q2 | $1.17M | Buy |
14,140
+355
| +3% | +$29.1K | 0.41% | 68 |
|
|
2021
Q1 | $1.04M | Buy |
13,785
+202
| +1% | +$14.7K | 0.4% | 67 |
|
|
2020
Q4 | $928K | Buy |
13,583
+3
| +0% | +$195 | 0.48% | 54 |
|
|
2020
Q3 | $793K | Sell |
13,580
-187
| -1% | -$11.6K | 0.49% | 53 |
|
|
2020
Q2 | $894K | Sell |
13,767
-148
| -1% | -$9.32K | 0.56% | 42 |
|
|
2020
Q1 | $826K | Buy |
13,915
+434
| +3% | +$29K | 0.62% | 38 |
|
|
2019
Q4 | $1M | Buy |
13,481
+2
| +0% | +$140 | 0.51% | 43 |
|
|
2019
Q3 | $850K | Sell |
13,479
-1,439
| -10% | -$85.3K | 0.47% | 48 |
|
|
2019
Q2 | $813K | Sell |
14,918
-248
| -2% | -$13.4K | 0.43% | 52 |
|
|
2019
Q1 | $818K | Buy |
15,166
+710
| +5% | +$43.8K | 0.44% | 49 |
|
|
2018
Q4 | $947K | Sell |
14,456
-12
| -0.1% | -$896 | 0.56% | 38 |
|
|
2018
Q3 | $1.14M | Sell |
14,468
-15
| -0.1% | -$1.07K | 0.55% | 38 |
|
|
2018
Q2 | $932K | Buy |
14,483
+1,613
| +13% | +$106K | 0.47% | 43 |
|
|
2018
Q1 | $801K | Buy |
12,870
+302
| +2% | +$21.7K | 0.42% | 54 |
|
|
2017
Q4 | $911K | Sell |
12,568
-3,065
| -20% | -$223K | 0.46% | 51 |
|
|
2017
Q3 | $1.27M | Sell |
15,633
-57
| -0.4% | -$4.51K | 0.65% | 31 |
|
|
2017
Q2 | $1.26M | Buy |
15,690
+549
| +4% | +$43.3K | 0.67% | 25 |
|
|
2017
Q1 | $1.19M | Buy |
15,141
+490
| +3% | +$39.1K | 0.69% | 24 |
|
|
2016
Q4 | $1.16M | Buy |
14,651
+1,472
| +11% | +$119K | 0.68% | 23 |
|
|
2016
Q3 | $1.17M | Buy |
13,179
+122
| +0.9% | +$11.5K | 0.72% | 22 |
|
|
2016
Q2 | $1.25M | Buy |
13,057
+79
| +0.6% | +$7.87K | 0.8% | 20 |
|
|
2016
Q1 | $1.35M | Buy |
12,978
+317
| +3% | +$30.8K | 1.02% | 16 |
|
|
2015
Q4 | $1.24M | Buy |
12,661
+788
| +7% | +$77.2K | 0.95% | 20 |
|
|
2015
Q3 | $1.15M | Buy |
11,873
+347
| +3% | +$36.5K | 1.04% | 20 |
|
|
2015
Q2 | $1.21M | Buy |
11,526
+423
| +4% | +$43.2K | 0.99% | 19 |
|
|
2015
Q1 | $1.15M | Buy |
11,103
+48
| +0.4% | +$4.86K | 0.95% | 20 |
|
|
2014
Q4 | $1.06M | Buy |
11,055
+98
| +0.9% | +$8.63K | 0.86% | 24 |
|
|
2014
Q3 | $872K | Hold |
10,957
| – | – | 0.71% | 35 |
|
|
2014
Q2 | $826K | Buy |
10,957
+169
| +2% | +$12.8K | 0.62% | 35 |
|
|
2014
Q1 | $808K | Sell |
10,788
-2,062
| -16% | -$146K | 0.63% | 34 |
|
|
2013
Q4 | $920K | Buy |
+12,850
| New | +$826K | 0.71% | 34 |
|
Other funds holding CVS
Peddock Capital Advisors's CVS Position: Q2 2026 in Review
Peddock Capital Advisors increased its CVS Health (CVS) stake by 0.13% in Q2 2026, buying an estimated $357 and bringing the position to 3,154 shares worth $326K. The position accounts for 0.07% of the portfolio, ranked #129.
Peddock Capital Advisors first reported a position in CVS in Q4 2013 and has held it in 51 quarters since. The position peaked at $2.12M in Q1 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Peddock Capital Advisors held 3,154 shares of CVS Health worth $326K as of Q2 2026.
- Peddock Capital Advisors bought 4 CVS Health shares in Q2 2026, an estimated $357.
- CVS Health made up 0.07% of Peddock Capital Advisors's portfolio in Q2 2026, its #129 holding.
- Peddock Capital Advisors first reported a position in CVS Health in Q4 2013 and has held it in 51 quarters since.
- Peddock Capital Advisors's CVS Health position peaked at $2.12M in Q1 2022.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Peddock Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.